George A Digenis

This inventor holds 12 USPTO granted patents. Top assignees: University of Kentucky Research Foundation, Czechoslovak Academy of Sciences. Active years: 1978-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George A Digenis. Retrieved from https://idiyas.com/inventor/george-a-digenis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 215(Granted Patents)

Company Filing History:

12 out of 903

University of Kentucky Research Foundation

patents

1 out of 1

Czechoslovak Academy of Sciences

patent

where one patent can have more than one assignee

Years Active: 1978-1999

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5922319 - Methods of treating eye conditions with human leukocyte elastase (HLE) (1999-07-13),

2. 5672359 - Multicompartment hard capsule with control release properties (1997-09-30),

3. 5539123 - Low molecular weight thiocarbamates as inhibitors of elastase, uses and (1996-07-23),

4. 5492692 - Coated products with potent anti-HIV and antimicrobial properties (1996-02-20),

5. 5380523 - High energy coprecipitate of nonoxynol oligomer, PVP and iodine having (1995-01-10),

6. 5162307 - Polymer bound elastase inhibitors (1992-11-10),

7. 5032402 - 3-hydroxy-N-methylpyrrolidone and use as transdermal enhancer (1991-07-16),

8. 5008245 - Novel peptidyl carbamate inhibitors of the enzyme elastase (1991-04-16),

9. 4973708 - 3-hydroxy-N-methylpyrrolidone and preparation thereof (1990-11-27),

10. 4643991 - Peptide elastase inhibitors and methods (1987-02-17),

11. 4202356 - Tobacco smoke filter material (1980-05-13),

12. 4115540 - Radiodiagnostic agent (1978-09-19),

Title: Innovations and Contributions of George A Digenis

Introduction

George A Digenis is a notable inventor based in Lexington, KY (US), recognized for his significant contributions to the field of medical treatments and drug delivery systems. With a total of 12 patents, Digenis has made strides in addressing eye conditions and enhancing pharmaceutical formulations.

Latest Patents

Among his latest patents, Digenis has developed methods for treating eye conditions using human leukocyte elastase (HLE). One method focuses on reducing corneal scarring or fibroblast proliferation by applying a specific amount of a free or polymer-bound HLE inhibitory agent to the affected area of the eye. Another innovative method aims to reduce neovascularization of corneal scar tissue through a similar application of HLE inhibitory agents. Additionally, he has created a multicompartment hard capsule with controlled release properties. This capsule is designed to incorporate pharmacologically active components in three or more distinct compartments, allowing for a tailored drug release profile.

Career Highlights

Digenis has worked with esteemed institutions such as the University of Kentucky Research Foundation and the Czechoslovak Academy of Sciences. His work in these organizations has contributed to advancements in research and development in the medical field.

Collaborations

Throughout his career, Digenis has collaborated with notable individuals, including Bushra J Agha and Alexander G Digenis. These partnerships have fostered innovation and the sharing of ideas in the realm of medical research.

Conclusion

George A Digenis stands out as a prominent inventor whose work has significantly impacted medical treatments and drug delivery systems. His innovative patents and collaborations reflect his dedication to advancing healthcare solutions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]